Erschienen in:
01.12.2006 | Topic Paper
Potential future options in the pharmacotherapy of female sexual dysfunction
verfasst von:
Stefan Ückert, Margit E. Mayer, Udo Jonas, Christian G. Stief
Erschienen in:
World Journal of Urology
|
Ausgabe 6/2006
Einloggen, um Zugang zu erhalten
Abstract
Female sexual dysfunction (FSD) is considered a common medical problem estimated to affect millions of women in the westernized countries. FSD has been classified into four different categories including sexual arousal disorder (FSAD), sexual desire disorder (HSDD), orgasmic disorder and sexual pain disorder. The focus of this article is the potential role of pharmacological compounds currently under development, in the treatment of sexual arousal and orgasmic disorders in order to enhance the sexual response in adult females. While a number of potential therapeutic options are available to date, not one of the pharmacological treatment regimens has been yet considered the Gold standard in the management of symptoms of FSD. This article reviews the rationale and potential benefits of using distinct drug formulations in the treatment of FSD.